Invited Perspective
There is compelling evidence that genes play a major role in the etiology of orofacial clefts (OFCs), which include 3 common forms: cleft lip with cleft palate (CLP), cleft lip (CL), and cleft palate (CP). Genome-wide linkage and association studies have identified more than 2 dozen genes associated with increased risk of OFCs at genome-wide significance levels (Beaty et al. 2016) . However, most of these highly significant markers identified in genome-wide studies are located outside of coding regions, so the biological mechanisms underlying these statistical associations remain elusive. Experimental studies in animal models and in vitro systems can address some of the gaps in our knowledge regarding biological pathways controlled by genetic variants associated with OFCs, but complementary studies in humans are still needed.
The emergence of affordable high-throughput "-omic" technologies has recently created a way to unify genomic, epigenomic, and transcriptome data collected from human samples, and now researchers can try to define connections between DNA variants and differential RNA expression. Understanding relationships between common variants in DNA sequence and RNA transcription could provide important clues about biological mechanisms (Albert and Kruglyak 2015) . For example, single-nucleotide polymorphisms (SNPs) in noncoding regions have been shown to control transcription levels at both nearby (termed -cis) and distal (termed -trans) genes, including genes that otherwise would not have been implicated based solely on the location of the SNP associated with disease (Hao et al. 2012; Zou et al. 2012; Li et al. 2013; Ongen et al. 2014; Lau et al. 2017) . SNPs in noncoding regions cannot result in structural changes to the protein gene product, but they could influence the quantity of RNA produced by regulating gene expression at the transcriptional level. Such SNPs controlling the quantity of gene expression are termed expression quantitative trait loci (eQTLs). Unlike the DNA sequence itself, patterns of gene expression differ by cell type and are critical to both cellular identity and function. Therefore, to better understand biological mechanisms, eQTL mapping (i.e., defining which SNPs are associated with RNA expression of which genes) can combine expression and association studies using samples from the same individuals when a relevant tissue is available. However, this ideal integrated eQTL mapping approach is difficult in OFC research. First, because OFC defects are characterized by absence of tissue, direct measurements of RNA expression (or other "-omics" measurements) are difficult. Furthermore, even if a relevant tissue could be obtained from a sample of affected children, the number of samples would be far too small to perform well-powered genome-wide association study (GWAS) discovery followed by integrated study of RNA expression. Fetal pluripotent precursor mesenchymal stem cells (MSCs) should be critical to the mechanisms controlling OFCs because these cells generate differentiated bone, cartilage, muscle, and adipocyte cells. Unfortunately, such cells are not easily accessible during early human development, so alternative approaches are needed.
In this issue of the Journal of Dental Research, PassosBuenos et al. (2017) used an alternative to the classic strategy of first performing a GWAS to identify common SNPs associated with risk of OFCs and then checking for association with quantitative measures of RNA expression in a relevant tissue from the same individuals. Instead, Passos-Buenos et al. first defined potential regulatory SNPs in a disease-relevant tissue (cultured MSCs from the orbicularis oris muscle) on a very modest sample of cell lines (only 46 subjects in total, all but 4 of whom had an OFC) and then performed a classic CL/P casecontrol association test using selected candidate SNPs. The authors mapped connections between 237,238 SNPs and more than 25,000 RNA transcripts and identified a dozen SNPs as potential eQTLs based on an empiric false discovery rate. The most significant eQTLs were then evaluated to see if eQTL genotypes were also associated with the risk of CL/P in a large Brazilian case-control study. Among the 36 top-ranked candidate regulatory SNPs, 1 eQTL also showed a significant association with CL/P risk. The eQTL associated with increased risk for CL/P in the Brazilian study was located in an exon of the MOGS gene but controls gene expression of MRPL53, a gene located over 8 kb downstream from the eQTL. Because the candidate eQTL SNPs were identified in a disease-relevant tissue (cultured MSCs), MRPL53 becomes a viable candidate gene for OFCs. The strongest evidence for the association between this SNP was observed among individuals estimated to have the highest proportion of Native American ancestry averaged across the genome in this Brazilian sample. In light of the higher prevalence for OFCs among Native American 735806J DRXXX10.1177/0022034517735806Journal of Dental ResearchIntegrating Gene Expression and Association Studies
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Journal of Dental Research 97 (1) populations (IPDTOC Working Group 2011; Butali et al. 2014; Allagh et al. 2015) , this observation may help explain some of the population-specific evidence from association studies seen in the literature (for both GWAS and candidate gene studies). Despite the statistical signal of association from their Brazilian cases and controls, however, the authors were unable to replicate evidence of genetic association in 2 independent samples (1 of European and 1 of Mayan ancestry). While this novel approach is intriguing and is based on a potentially relevant tissue, the small number of cultured stem cells and the lack of replication remain obvious limitations of this study.
The innovative approach applied by Passos-Buenos et al. (2017) includes generating a unique MSC data resource suitable for gene expression studies, and their initial findings may open new directions of research. Future work comparing their results with similar "reverse" genetics approaches may add weight to the evidence for specific biological mechanisms controlling risk to OFCs. However, further studies will be needed to fully understand the lack of replication in their samples of European and Mayan ancestry. Finally, transcription data from the cultured MSCs generated here could well be leveraged in future experimental work to provide further functional insights for known OFC risk variants, including those previously identified in genome-wide screens, as well as enabling researchers to determine whether or not easily accessible tissues (e.g., white blood cells) could be useful in additional functional studies relevant to OFCs.
Author Contributions
C. Ladd-Acosta, contributed to conception, design, and data acquisition, drafted and critically revised the manuscript; T.H. Beaty, contributed to conception, design, and data interpretation, drafted and critically revised the manuscript. Both authors gave final approval and agree to be accountable for all aspects of the work.
